RESEARCHER PROFILE

Diego Dal Ben

← Back to Università di Camerino

D

Università di Camerino

Adenosine and Purinergic SignalingReceptor Mechanisms and SignalingBiochemical and Molecular ResearchSynthesis and biological activitySynthesis and Characterization of Heterocyclic Compounds

Diego Dal Ben works in Adenosine and Purinergic Signaling, Receptor Mechanisms and Signaling, Biochemical and Molecular Research, Synthesis and biological activity, Synthesis and Characterization of Heterocyclic Compounds. Recorded institutional associations include Università di Camerino.

149Publications
4,657Citations
28H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. The P2X7 Receptor in Infection and Inflammation

    2017 · 1,259 citations
  2. Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease

    2020 · 1,130 citations
  3. Toward the rational design of protein kinase casein kinase-2 inhibitors

    2002 · 155 citations
  4. P2X7 Receptor as a Therapeutic Target

    2016 · 111 citations
  5. Fragment optimization for GPCRs by molecular dynamics free energy calculations: Probing druggable subpockets of the A 2A adenosine receptor binding site

    2017 · 61 citations
  6. Design, synthesis and evaluation in an LPS rodent model of neuroinflammation of a novel 18F-labelled PET tracer targeting P2X7

    2017 · 60 citations
  7. Innovative functional cAMP assay for studying G protein-coupled receptors: application to the pharmacological characterization of GPR17

    2011 · 56 citations
  8. 8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands

    2009 · 55 citations
  9. Pyrazolo[1,5-c]quinazoline derivatives and their simplified analogues as adenosine receptor antagonists: Synthesis, structure–affinity relationships and molecular modeling studies

    2012 · 55 citations
  10. A2A Adenosine Receptor and its Modulators: Overview on a Druggable GPCR and on Structure-Activity Relationship Analysis and Binding Requirements of Agonists and Antagonists

    2008 · 53 citations
  11. Adenosine Receptors as Neuroinflammation Modulators: Role of A1 Agonists and A2A Antagonists

    2020 · 52 citations
  12. Interaction Model for Anthracycline Activity against DNA Topoisomerase II

    2004 · 48 citations
  13. Medicinal Chemistry of P2X Receptors: Agonists and Orthosteric Antagonists

    2015 · 48 citations
  14. Purinergic P2X receptors: Structural models and analysis of ligand-target interaction

    2014 · 45 citations
  15. The G Protein‐Coupled Receptor GPR17: Overview and Update

    2016 · 45 citations
  16. Update on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applications

    2019 · 44 citations
  17. DNA Topoisomerase II Structures and Anthracycline Activity: Insights into Ternary Complex Formation

    2007 · 43 citations
  18. Evidence for the Existence of a Specific G Protein‐Coupled Receptor Activated by Guanosine

    2011 · 43 citations
  19. Adenosine Receptor Modeling: What Does the A2A Crystal Structure Tell Us?

    2010 · 41 citations
  20. Neuroprotective potential of adenosine A1 receptor partial agonists in experimental models of cerebral ischemia

    2019 · 38 citations
  21. Amide bond direction modulates G-quadruplex recognition and telomerase inhibition by 2,6 and 2,7 bis-substituted anthracenedione derivatives

    2007 · 36 citations
  22. N6-Methoxy-2-alkynyladenosine Derivatives as Highly Potent and Selective Ligands at the Human A3Adenosine Receptor

    2007 · 36 citations
  23. Highlights on the Development of A2A Adenosine Receptor Agonists and Antagonists

    2006 · 36 citations
  24. The 1,2,4-Triazolo[4,3-a]pyrazin-3-one as a Versatile Scaffold for the Design of Potent Adenosine Human Receptor Antagonists. Structural Investigations to Target the A2AReceptor Subtype

    2017 · 35 citations
  25. The aminopyridine-3,5-dicarbonitrile core for the design of new non-nucleoside-like agonists of the human adenosine A2B receptor

    2018 · 35 citations
  26. Synthesis and Biological Evaluation of 2-Alkynyl-N6-methyl-5′-N-methylcarboxamidoadenosine Derivatives as Potent and Highly Selective Agonists for the Human Adenosine A3Receptor

    2009 · 34 citations
  27. Adenosine A2A Receptor Antagonists: New 8‐Substituted 9‐Ethyladenines as Tools for in vivo Rat Models of Parkinson's Disease

    2009 · 33 citations
  28. Antiviral Properties of Deazaadenine Nucleoside Derivatives

    2006 · 29 citations
  29. Molecular modeling study on potent and selective adenosine A3 receptor agonists

    2010 · 27 citations
  30. Exploring the 7-oxo-thiazolo[5,4-d]pyrimidine core for the design of new human adenosine A3 receptor antagonists. Synthesis, molecular modeling studies and pharmacological evaluation

    2015 · 26 citations
  31. P2X3 Receptor Ligands: Structural Features and Potential Therapeutic Applications

    2021 · 26 citations
  32. Simulation and comparative analysis of binding modes of nucleoside and non-nucleoside agonists at the A2B adenosine receptor

    2013 · 25 citations
  33. Antiproliferative Evaluation of Isofuranodiene on Breast and Prostate Cancer Cell Lines

    2014 · 24 citations
  34. Modifications on the Amino-3,5-dicyanopyridine Core To Obtain Multifaceted Adenosine Receptor Ligands with Antineuropathic Activity

    2019 · 23 citations
  35. Different efficacy of adenosine and NECA derivatives at the human A3 adenosine receptor: Insight into the receptor activation switch

    2013 · 22 citations
  36. Novel potent and highly selective human A3 adenosine receptor antagonists belonging to the 4-amido-2-arylpyrazolo[3,4-c]quinoline series: Molecular docking analysis and pharmacological studies

    2008 · 22 citations
  37. Design, synthesis, and biological evaluation of new mitonafide derivatives as potential antitumor drugs

    2008 · 22 citations
  38. Synthesis, structure–affinity relationships, and molecular modeling studies of novel pyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists

    2011 · 22 citations
  39. Antioxidant-Conjugated 1,2,4-Triazolo[4,3-a]pyrazin-3-one Derivatives: Highly Potent and Selective Human A2A Adenosine Receptor Antagonists Possessing Protective Efficacy in Neuropathic Pain

    2019 · 22 citations
  40. 1,2,4-Triazolo[1,5-a]quinoxaline derivatives and their simplified analogues as adenosine A3 receptor antagonists. Synthesis, structure–affinity relationships and molecular modeling studies

    2014 · 22 citations
  41. Imidazo[1,2-a]pyrazin-8-amine core for the design of new adenosine receptor antagonists: Structural exploration to target the A3 and A2A subtypes

    2016 · 20 citations
  42. Purinergic Ligands as Potential Therapeutic Tools for the Treatment of Inflammation-Related Intestinal Diseases

    2018 · 20 citations
  43. Comparison and optimization of transient transfection methods at human astrocytoma cell line 1321N1

    2011 · 19 citations
  44. Adenine-Based Acyclic Nucleotides as Novel P2X 3 Receptor Ligands

    2009 · 19 citations
  45. Emerging Roles of Purinergic Signaling in Diabetes

    2018 · 19 citations
  46. New potent and selective A1 adenosine receptor antagonists as potential tools for the treatment of gastrointestinal diseases

    2018 · 19 citations
  47. GPR17 receptor modulators and their therapeutic implications: review of recent patents

    2019 · 19 citations
  48. The Anti-Inflammatory and Pain-Relieving Effects of AR170, an Adenosine A3 Receptor Agonist, in a Rat Model of Colitis

    2020 · 19 citations
  49. Neuropeptide S Receptor: Recent Updates on Nonpeptide Antagonist Discovery

    2011 · 18 citations
  50. Exploring the 2- and 5-positions of the pyrazolo[4,3-d]pyrimidin-7-amino scaffold to target human A1 and A2A adenosine receptors

    2016 · 18 citations

← Return to the university profile